Publications

2003

Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, et al. Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma. J Clin Oncol. 2003;21(16):3051-9.
Chen X, Hoda SA, Petrovic L. Images in pathology: Helicobacter heilmannii gastritis. Int J Surg Pathol. 2003;11(4):315.
Yao DX, Hoda SA, Yin DY, Kuhel WI, Harigopal M, Resetkova E, et al. Interpretative problems and preparative technique influence reliability of intraoperative parathyroid touch imprints. Arch Pathol Lab Med. 2003;127(1):64-7.
Lesinski GB, Anghelina M, Zimmerer J, Bakalakos T, Badgwell B, Parihar R, et al. The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest. 2003;112(2):170-80.
Feldman E, Najfeld V, Schuster M, Roboz G, Chadburn A, Silver RT. The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate. Exp Hematol. 2003;31(8):702-7.
Fournier E, Isakoff SJ, Ko K, Cardinale CJ, Inghirami GG, Li Z, et al. The B cell SH2/PH domain-containing adaptor Bam32/DAPP1 is required for T cell-independent II antigen responses. Curr Biol. 2003;13(21):1858-66.
Zhang Y, Morrone G, Zhang J, Chen X, Lu X, Ma L, et al. CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein. EMBO J. 2003;22(22):6057-67.
Gu L, Zheng H, Murray SA, Ying H, Xiao Z-. Deregulation of Cdc2 kinase induces caspase-3 activation and apoptosis. Biochem Biophys Res Commun. 2003;302(2):384-91.
Rand JH. The antiphospholipid syndrome. Annu Rev Med. 2003;54:409-24.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700